Guinea vs Papua New Guinea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Guinea
2.8%
in 2024
Papua New Guinea
2.5%
in 2024
Guinea rank
8th
Papua New Guinea rank
11th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Guinea
- Papua New Guinea
How they compare
Guinea currently reports 2.8% against 2.5% in Papua New Guinea, a difference of 0.3%.
That makes Guinea's figure about 1.1 times Papua New Guinea's.
Across all 10 years both countries report, Guinea has been ahead every year.
Guinea ranks 8th and Papua New Guinea ranks 11th of 246 countries.
Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 2.0% | 0.8% | Guinea |
| 2020s | 2.7% | 2.4% | 0.3% | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Guinea or Papua New Guinea?
- Guinea, at 2.8% against 2.5% in Papua New Guinea as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Guinea and Papua New Guinea?
- 0.3%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Papua New Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do Guinea and Papua New Guinea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Guinea ranks 8th and Papua New Guinea ranks 11th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.